FAST NEWS: Simcere Pharma New Co-CEO Sends Investors Scurrying
The latest: Simcere Pharmaceutical Group Ltd. (2096.HK) announced late Wednesday that executive director Tang Renhong has been appointed as Co-CEO and will assist Chairman and CEO Ren Jinsheng in leading…
As U.S. Takes Aim at China Drug Makers, Innovators Appear at Biggest Risk
Washington’s campaign to keep cutting-edge technology out of China took a new twist late last week with the addition of Chinese medical companies to U.S. blacklists Key takeaways: Washington has…
Drug Maker Simcere Ditches Cell Therapy to Focus on Oncology
Company sells money-losing Simgene unit for $16 million, following recent deals to commercialize two new cancer drugs in China Key Takeaways: New China licensing deals and oncology focus come amid…
RELATED ARTICLES
-
Profit setback for Simcere Pharma in novel drugs quest
2096.HK -
FAST NEWS: Simcere gets exclusive rights to innovative influenza drug
2096.HK
-
FAST NEWS: Simcere’s Covid drug trial shows promising results
2096.HK
-
Akeso marks profit milestone with swift rights issue
9926.HK
-
With no cure in sight, drugs firm LianBio begins exit strategy
LIAN.US
